Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Alto Ingredients Q2 2024 GAAP EPS $(0.05) Beats $(0.10) Estimate, Sales $236.468M Beat $232.482M Estimate

Author: Benzinga Newsdesk | August 06, 2024 05:03pm
Alto Ingredients (NASDAQ:ALTO) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.10) by 50 percent. The company reported quarterly sales of $236.468 million which beat the analyst consensus estimate of $232.482 million by 1.71 percent. This is a 25.47 percent decrease over sales of $317.297 million the same period last year.

Posted In: ALTO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist